Localized microbubble cavitation-based antivascular therapy for improving HCC treatment response to radiotherapy

Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality worldwide and the fastest growing malignancy in the United States. With a 5-year survival rate below 12%, effective therapies for HCC are needed. Current treatments for HCC include microwave and radiofrequency ablation, hi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Lett
Autors principals: Daecher, Annemarie, Stanczak, Maria, Liu, Ji-Bin, Zhang, Jie, Du, Shisuo, Forsberg, Flemming, Leeper, Dennis B., Eisenbrey, John R.
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5693746/
https://ncbi.nlm.nih.gov/pubmed/28969964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2017.09.037
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars